Search for: "PFIZER V TEVA PHARMA"
Results 101 - 120
of 143
Sorted by Relevance
|
Sort by Date
5 Apr 2023, 5:18 am
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
31 May 2011, 8:38 pm
Labs. v. [read post]
8 Jul 2009, 7:04 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Apr 2014, 11:51 am
Natco Pharma (Fed. [read post]
27 Dec 2012, 3:47 pm
Schwarz Pharma, Inc., ___ Fed. [read post]
13 Feb 2013, 11:49 pm
The invalidation was pursuant to a law suit bought by BMS (the patentee) against Teva, a leading Israeli generic company. [read post]
28 Dec 2007, 1:00 am
: (IPBiz),Sinorgchem v. [read post]
8 May 2020, 6:57 pm
” Pfizer, Inc. v. [read post]
18 Jan 2013, 2:06 pm
We already did that in connection with the original decision in Conte v. [read post]
26 Sep 2007, 1:04 pm
See: In Re Gabapentin Patent Litigation (involving Warner-Lambert, Pfizer and Godecke Aktiengesellschaft v. [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
18 Feb 2013, 12:46 am
Madhulika reported that the Patent Office revoked Pfizer’s patent on Sunitib- an exorbitantly priced drug. [read post]
29 Feb 2008, 8:00 am
: (creativecommons.org)Pharma & BiotechPharma & Biotech - GeneralScience Commons news: A commons-sense approach to winning the drug discovery lottery: (creativecommons.org),India: Hindu Business Line reports on why pharma companies are pushing for tax incentives: (Spicy IP), India: J Mitra gets injunction against Span Diagnostics in patent dispute before Delhi High Court over device used in detection of Hep C: (Generic Pharmaceuticals & IP), India: Patent… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on… [read post]
20 Jun 2008, 8:07 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Associated Press – AP files seven DMCA takedowns against Drudge Retort blog over users linking to its stories: (The Trademark Blog), (Techdirt), (Out-Law), (Electronic Frontier Foundation), (IPKat), (The Trademark Blog), ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited… [read post]
10 Nov 2013, 6:37 am
Pravin then alluded to decisions involving patents owned by Pfizer and Merck, in which the outcome was rather better for the proprietary pharma sector. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
12 Oct 2011, 8:31 am
Prods. v. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over… [read post]
22 Mar 2016, 4:00 am
Although manufacturers are still fragmented, consolidations continue based on “better rationales” (given the standard merger rewards may not necessarily exist): including Pfizer/Hospira, Teva/Actavis and focused start-ups. [read post]
